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The gene for the human poliovirus receptor (hPVR/CD155) is the founding member of a new family of genes encoding
proteins belonging to the immunoglobulin superfamily. To determine whether CD155 is expressed during mammalian
development, we have made use of the previously characterized promoter of the CD155 gene and generated mice transgenic
for a CD155 promoter-driven b-galactosidase reporter gene. Expression of the reporter gene in transgenic embryos was
observed during midgestation in anterior midline structures of the developing central nervous system and in the neuroretina.
During that period, reporter gene expression appeared within the notochord and floor plate along the entire spinal cord
reaching into the caudal diencephalon. In addition, transgene expression was observed in axonal projections emanating from
retinal ganglion cells forming the optic nerve to reach the future region of the optic chiasm. Analysis of expression of CD155
during human embryonic development confirmed the distribution of reporter gene expression specified by CD155 promoter
activity. The anatomical distribution of CD155 promoter activity during embryogenesis matches that of transacting factors
previously identified to regulate transcription of the CD155 gene. Expression of CD155 within embryonic structures giving
rise to spinal cord anterior horn motor neurons may explain the restrictive host cell tropism of poliovirus for this cellular
compartment of the CNS. © 2000 Academic Press
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CD155 (also known as hPVR) is the term for four
isotypes of glycoproteins belonging to the immunoglob-
ulin superfamily (IGSF) that have been identified as the
receptors for poliovirus (Mendelsohn et al., 1989). Its
gene is the founding member of a new family of primate
and rodent genes that encode polypeptides with a com-
mon structural arrangement of three extracellular (V-C2-
C2) domains (Fig. 1A; Mendelsohn et al., 1989; Koike et
l., 1990; Wimmer et al., 1993). CD155 is expressed in
our isoforms: CD155a and -d are membrane-bound vari-
nts that differ only in the sequence of their cell-internal
-terminal domain, while CD155b and -g are secreted
soforms lacking the transmembrane domain (Fig. 1;
oike et al., 1990; Wimmer et al., 1993). CD155a and -d
are type Ia single-pass transmembrane glycoproteins
with apparent M r of .80,000 (the core polypeptides are
2.5 and 40 kDa, respectively; Bernhardt et al., 1994a).
inding of poliovirus occurs at the V-domain of the
olypeptide (Bernhardt et al., 1994b; Belnap et al., 2000;
e et al., 2000).
Only the CD155 isoforms and their simian counter-
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248arts mediate poliovirus infectivity (Koike et al., 1992).
he human poliovirus receptor-related genes 1 (hPRR1;
opez et al., 1995) and 2 (hPRR2; Eberle et al., 1995) as
well as the rodent molecules mPRR2 [previously referred
to as mouse poliovirus receptor homolog, MPH (Morri-
son and Racaniello, 1992)] and mTage4 (Chadeneau et
al., 1994) lack poliovirus binding activity. Interestingly,
hPRR1 and hPRR2 have been found to serve as recep-
tors for a-herpesviruses (Geraghty et al., 1998) and pseu-
dorabies virus (Warner et al., 1998), respectively.
It is believed that CD155 may play a critical role in the
determination of specific neuropathogenicity of poliovi-
rus that limits susceptibility to spinal and brainstem mo-
tor neurons (Wimmer et al., 1993; Gromeier et al., 1995).
t has been difficult, however, to corroborate this as-
umption. Attempts to match the anatomical distribution
f CD155 with susceptibility to poliovirus failed because
f the difficulty in detecting CD155 expression within
dult primate neural tissues. Available evidence sug-
ests expression levels of these proteins to be exceed-
ngly low, both in human tissues and in human tissue
ulture cell lines (Bernhardt et al., 1994a; Solecki et al.,
1997).
Mammalian, avian, and insect cell adhesion mole-
cules belonging to the IGSF are expressed in key struc-
tures exerting developmental cues within the embryonic
CNS (Colamarino and Tessier-Lavigne, 1995; Tessier-
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249DEVELOPMENTAL EXPRESSION OF CD155 IN THE CNSLavigne and Goodman, 1996; Yoshihara et al., 1991).
Similarity of CD155 with insect IGSF molecules that play
a role in nervous system development, e.g., Drosophila
amalgam (Hellen et al., 1989; Seeger et al., 1988), grass-
hopper lachesin (Karlstrom et al., 1993), or Drosophila
irreC (Ramos et al., 1993), prompted us to investigate the
expression of CD155 during embryonic development.
We have studied first the basic structure of the regu-
latory element of the CD155 gene and identified trans-
acting factors likely to be involved in the regulation of the
CD155 gene (Solecki et al., 1997, 1999, 2000). This has
allowed us to construct a vector in which expression of
a reporter gene (b-galactosidase; LacZ) is controlled by
he CD155 upstream region. Since nonprimate homologs
o CD155 have not been identified, experimental animal
odels to analyze expression during embryonic devel-
pment are not available. Therefore, we used a CD155/
acZ reporter gene vector to generate transgenic mice
ith the aim of following a developmental profile of
eporter gene expression, a strategy employed success-
ully previously (Goring et al., 1987; Rossant et al., 1991).
o corroborate the pattern of CD155 promoter activity in
ransgenic mice, we performed immunohistological anal-
ses for the detection of CD155 in human embryonic
issues.
In CD155/LacZ tg mice, the expression of lacZ under
he control of upstream sequences of CD155 was de-
ected in anterior midline structures of the developing
NS during a defined period of embryonic development.
ransgene expression was highly restricted to floor plate
nd notochord. These structures determine the ventral
olarity of the spinal cord and differentiation of motor
eurons (Tanabe and Jessell, 1996; Placzek et al., 1993).
nterestingly, CD155 promoter activity was also detected
n the nerve fiber layer of the retina, the optic nerve, and
he region of the future optic chiasm. In accordance with
ur transgenic studies, CD155 expression was detected
n the neuroretina of human embryos in parallel stages of
ntogeny.
CD155 promoter activity within the evolving embryonic
NS is restricted to structures giving rise to spinal an-
erior horn motor neurons, a population of neural cells
hat is uniquely susceptible to poliovirus. This associa-
ion suggests that the distribution of CD155 may indeed
irect poliovirus tropism toward a select group of spe-
ialized neurons within the primate CNS.
RESULTS
eneration of CD155/LacZ tg mice
To generate transgenic mice for the analysis of CD155
romoter activity during embryogenesis, we have con-
tructed an expression vector containing a 3.0-kb frag-
ent of the CD155 upstream region (Solecki et al., 1997,999) linked to the LacZ reporter (Fig. 1B; see Materials
nd Methods). The vector, originally supplied to us by J.
e
Cossant, was tested to ascertain that no cryptic expres-
ion of the reporter gene occurs after transfection into
issue culture cells (data not shown). As was reported
reviously, the gene for CD155 is expressed in most
uman tissue culture cell lines tested with the notable
xception of some lymphatic cell lines, including Raji
ells (an Epstein–Barr virus-transformed lymphoblas-
oma cell line). The CD155 promoter is silent in Raji cells
Solecki et al., 1997, 1999). The CD155/LacZ vector was
herefore analyzed for activity in Ntera-2, a human ter-
tocarcinoma cell line expressing CD155, as well as in
aji cells. After transfection of vector DNA, b-galactosi-
ase activity was observed in Ntera-2 cells but not in Raji
ells (Fig. 2). This observation is an indication that the
egulation of reporter gene expression in the CD155/
acZ vector may correlate with that of the endogenous
ellular CD155 promoter.
Further support for our assumption that the 3.0-kb
romoter fragment is likely to function adequately in
ransgenic mice comes from studies with mice trans-
enic for the CD155 gene. These mice that were gener-
ted with CD155 upstream sequences of similar length
evelop neurological symptoms identical to primate po-
iomyelitis when injected with poliovirus (Ren et al., 1990;
oike et al., 1991; Gromeier et al., 1996). This indicates
hat the function of the CD155 poliovirus receptor in
D155 tg mice mimics that observed in primates. Based
n these results, we believe that the CD155 promoter
ragment employed in our studies harbors the necessary
is-acting elements to generate cell type-specific gene
xpression in vivo.
Genotypical analysis of newborn CD155/LacZ tg mice
enerated from germline manipulated embryos revealed
he presence of the transgene in four independent
ounder lines. All four independent founder lines were
xamined for the expression pattern of LacZ under the
ontrol of CD155-specific upstream sequences during
mbryonic development. To this end, whole-mount stain-
ng of transgenic mouse embryos at various gestational
tages with the LacZ substrate X-gal (see Materials and
ethods) was performed (Fig. 3). At the gestational age
hown [embryo day 12.0 (E12.0)], reporter gene expres-
ion in all founder lines was detected in anterior midline
tructures spanning the neuraxis from the caudal dien-
ephalon to the lower sacral spinal cord. Although the
ntensity of the signal was delicate in lower lumbar and
acral regions of the spinal cord, it was reproducibly
een in all four independent founder lines (Figs. 3 and 4).
eporter gene expression in the developing brain
In E12.0 embryos, CD155 promoter activity specified
entral midline structures of the spinal cord that ex-
ended cranially beyond the myelencephalon and mes-
ncephalon into the caudal diencephalon (Figs. 4A–4G).
erebral structures of CD155/LacZ tg mice that ex-
i
s ase I fo
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250 GROMEIER ET AL.pressed the reporter are linked to floor plate markers
common to corresponding regions in the spinal cord
(Colamarino and Tessier-Lavigne, 1995; Placzek et al.,
1993). Maximal levels of LacZ activity were detected
around E12.0 within the presumptive supraspinal floor
plate. At that stage, anterior parts of the mesencephalon
lining the median sulcus were delineated by LacZ activity
(Figs. 4A and 4B) while the rostral boundary of floor plate
according to LacZ expression was the caudal dienceph-
alon (Fig. 4A). Focal centers of transgene expression
within the anterior midbrain extended caudally through-
out the myelencephalon delineating the medullary raphe
(Fig. 4D). In addition to regions believed to functionally
correspond to floor plate, transgene expression was ob-
served in other midline structures: developing pituitary
(Fig. 4C) and outlining the path of the optic nerve and
future region of the optic chiasm (Figs. 4C and 4D). In
parallel with our findings of CD155 promoter activity in
the spinal cord (see below) enzymatic activity decreased
FIG. 1. Structure of CD155a (A), the CD155/LacZ transgene (B), and t
is indicated on top. The lengths of individual domains subdivided by the
by numbers. (B) The CD155/LacZ transgene consists of a 3000-bp CD15
consensus signal (SDK), and the open reading frame of b-galactosida
ndicate the region containing multiple transcriptional initiation sites (
tippled box represents the coding region of exon 1. The location of DN
nd AP-2 is shown (Solecki et al., 1997, 1999).rapidly after E12.0. Weak staining of the anterior mesen-
cephalon, the medullary raphe, and the region of thefuture optic nerve and chiasm as well as the neuroretina
at E13.0 was altogether absent in E19.0 embryos (data
not shown). Nonspecific enzymatic activity was ex-
pressed within the endolymphatic sac (Fig. 4C), which
stained positive in nontransgenic embryos at all stages
(not shown for nontransgenic embryos).
Reporter gene expression in the spinal cord during
embryonic development
In CD155/LacZ tg mice, transgene expression was
readily detectable within the spinal cord. Measured by
whole-mount staining of transgenic offspring, expression
of the reporter gene within the spinal cord became ap-
parent at approximately E10.5 (data not shown). As with
staining observed within the developing brain, maximal
intensity and most extensive distribution of staining prod-
uct throughout the embryonic CNS were observed at
E12.0 to E12.5 (Figs. 4A–4G). At that time, blue staining
55 core promoter (C). (A) The overall domain arrangement of CD155a
ine disulfide bonds characteristic for the IG-like domains are indicated
eam sequence (harboring the core promoter), a Shine-Dalgarno/Kozak
The CD155 core promoter (numbering: A of ATG 5 11). The brackets
i et al., 1997). The transcribed region is indicated by an open box; a
otprints known to mediate binding to transcriptional regulators NRF-1he CD1
cyste
5 upstr
se. (C)
Soleckproduct could be distinguished forming an intracranial
formation that extended caudally along the spinal axis to
(
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251DEVELOPMENTAL EXPRESSION OF CD155 IN THE CNSreach approximately the region corresponding to the
42nd somites.
LacZ activity was restricted to ventral midline struc-
tures of the developing CNS (Figs. 4A–4G). Structures
distinguished by reporter gene expression at the level of
the spinal cord were notochord, floor plate, and the
anterior horn proper (Figs. 4E and 4F, compare to Fig.
7D). The set of structures characterized by CD155 pro-
moter activity is the source for inductive signals for motor
neuron differentiation and determines ventral spinal cord
FIG. 2. Reporter gene expression driven by the 3.0-kb CD155 pro-
moter fragment in Ntera-2 and Raji cells after transfection of CD155/
LacZ cDNA. CD155/LacZ cDNA and its promoter-less derivative SD-
K.LacZpA128 were transfected into Ntera-2 and Raji cells. The effi-
ciency of all transfections was monitored by cotransfection of
experimental plasmids with pRL-TK (a Renilla luciferase expression
vector; see Materials and Methods). LacZ activity measured was nor-
malized according to the level of Renilla luciferase activity in the
transfected cell lysates. Background LacZ activity produced by the
promoter-less SDK.LacZpA128 was given the arbitrary value of 1 and
the reporter gene activity yielded by transfection of CD155/LacZ was
plotted relative to that value. The results shown represent data from
three independent experiments.
FIG. 3. Whole-mount staining of CD155/LacZ tg embryos with X-Gal.
A) An E12.0 embryo shows distribution of blue staining product along
he spinal axis extending cranially into the developing brain. (B) Non-
ransgenic siblings treated in parallel did not reveal macroscopically
isible levels of LacZ expression.polarity. A schematic diagram of the anatomical relation-
ship of notochord, floor plate, and ventral spinal cord in
the developing CNS is provided in Fig. 7.
At E12, the spinal distribution of transgene expression
was preponderantly cervico-thoracic with less intense
staining evident in lumbo-sacral regions of the cord
FIG. 4. Reporter gene expression within the developing embryonic
CNS. As indicated in the center, sections were obtained from upper
cephalic (A, B), midcephalic (C, D), cervical (C1–C3; E), midthoracic
(T3–T6; F), and lumbar regions (L2–L5; G). Serial transcephalic hori-
zontal sections of an E12.0 CD155/LacZ tg embryo (A–D) stained with
X-Gal demonstrated the anatomical distribution of CD155 promoter
activity. Transgene expression was detected in anterior midline struc-
tures from the most rostral part in the anterior pole of the caudal
diencephalon (A; di) throughout the anterior mesencephalon (A–C; me)
extending throughout the myelencephalon (D; mr) into the high cervical
spinal cord (E). Within the spinal cord the main structures visible
through positive staining are the floor plate and notochord (E, F; fp, nc).
Diffuse staining within the anterior horns of the spinal cord indicates
the presence of reporter gene expression in this area as well (E, F). di,
diencephalon; pca, posterior cerebral artery; me, mesencephalon; mca,
middle cerebral artery; p, pituitary; es, endolymphatic sac; oc, region of
future optic chiasm; ba, basilar artery; mr, medullary raphe; fp, floor
plate; nc, notochord; ah, anterior horn. Whole-mount stained embryos
were cryosectioned at a thickness of 40 mm and counterstained
with eosin. Scale bars for A–D, E–G, and the center panel represent
0.45 mm.(Figs. 4E–4G). We observed the focus of intensity of
transgene expression to shift caudally toward the lower
1
(
252 GROMEIER ET AL.thoracic and lumbo-sacral areas of the spinal cord at
E12.5–E13.0 (data not shown). At developmental stages
later than E12.0 intensity of transgene expression dimin-
ished as judged by the weakening reporter gene activity
in those structures identified to harbor CD155 promoter
activity. Transgenic embryos assayed in perinatal stages
of development (E16.5 to E19) were frozen and cryosec-
tioned prior to the staining reaction. Transverse sections
through the spinal cord of E16.5–E19 embryos thus
treated did not reveal specific LacZ activity (data not
shown).
Throughout the short period of histochemically detect-
able CD155 promoter activity in CD155/LacZ tg mouse
embryos (approximately E10.5–E13.0) the distribution of
transgene expression was limited to anterior midline
structures of the CNS with gradual progression caudally.
CD155 promoter activity extended cranially into areas
that have been demonstrated to functionally correspond
to the floor plate at the level of the spinal cord (see
below). All four transgenic founder lines analyzed
showed an identical pattern of reporter gene activation,
both in anatomical and in temporal distribution.
CD155 promoter activity within the developing ocular
system
In addition to ventral midline structures along a major
extension of the neuraxis we detected CD155 promoter
activity in the developing visual system (Figs. 5A–5C).
Expression of the reporter gene was observed in ret-
inofugal fibers constituting the nerve fiber layer of the
developing retina. Positively staining axons converged in
the optic disk and extended through the optic stalk along
the path of progression of the optic nerve toward the
region of the future optic chiasm (Figs. 4C, 5B, and 5C).
CD155 promoter activity within retinal ganglion cells pro-
gressed in parallel with axonogenesis and did not in-
volve the retinal ganglion cell somata (Fig. 5C). The
temporal pattern of CD155 promoter activity during on-
togeny of the visual system overlapped with the peak of
reporter gene expression within the spinal cord and
brain. At E12.5, staining of axonal bundles within the
nerve fiber layer (Figs. 5B and 5C) extended along the
path of optic nerve advance into the optic stalk (for
anatomical orientation refer to Fig. 5A) with some LacZ
activity within the region of the future optic chiasm (Fig.
4C). Reporter gene activity was detected simultaneously
within the developing lens (Figs. 5B and 4C). We did not
detect reporter gene expression within the optic tract
beyond the region of the future optic chiasm toward the
tectum.
Expression of CD155 during primate embryonic
developmentTo corroborate the activity pattern of the CD155 pro-
moter during midgestation in transgenic mice, we ana-lyzed CD155 expression in human embryos of different
gestational ages (Figs. 6A–6I). Immunohistochemical
probing for CD155 in the embryonic human retina was
performed using the monoclonal antibody D171 against
CD155 (Bernhardt et al., 1994a). This antibody was used
to isolate and clone the CD155 gene (Mendelsohn et al.,
989) and has been tested for specificity in tissue culture
Bernhardt et al., 1994a,b), in tissues of CD155 tg mice,
as well as in postmortem tissues derived from the human
CNS. Immunohistochemical experiments using cell lines
expressing CD155 as well as tissues derived from CD155
tg mice were performed to optimize staining conditions
(data not shown).
Treatment of tissue sections from human ocular tis-
sues revealed an expression pattern paralleling CD155
promoter activity in CD155/LacZ tg mice (Fig. 6; compare
with Fig. 5). Expression of CD155 was detected within the
nerve fiber layer of the embryonic retina (Fig. 6B). As
seen in CD155/lacZ tg mice, CD155 promoter-driven ex-
pression may be limited to a midgestational period, be-
cause expression in human embryos was almost unde-
tectable at 16 weeks gestational age (Fig. 6E) and was
altogether absent in adult retina (Fig. 6H). CD155 could
not be demonstrated immunohistochemically with cer-
tainty in sections of human embryonic spinal cord (data
not shown). This may be due to the locally and tempo-
rally restricted expression of CD155 and the difficulty of
obtaining human embryonic tissues of those defined
areas exhibiting CD155 promoter activity at a certain
gestational age. Furthermore, as observed in CD155/
LacZ tg mice, in which CD155 promoter activity was
clearly stronger in the neuroretina, expression within the
developing human spinal cord may be weaker than in the
ocular system (Figs. 3, 4, and 5).
DISCUSSION
The isotypes of the cell surface proteins now recog-
nized as CD155 have been uncovered because they
function as the human receptor for poliovirus (Mendel-
sohn et al., 1989; Koike et al., 1990). The physiological
function(s) of these proteins, however, has thus far
eluded identification. This is partly due to the exceed-
ingly low levels of CD155 expression in postpartal human
tissues precluding conclusive immunohistological detec-
tion of CD155 (Guo and Wimmer, unpublished results).
The expression pattern and function of CD155, however,
are likely to shed light also on the unique mechanism of
the pathogenesis of poliomyelitis. Neuropathological
damage due to poliovirus infection is strikingly specific,
affecting only a restricted number of spinal cord motor
neurons (Wimmer et al., 1993; Gromeier et al., 1995) to
give rise to the characteristic clinical features of paralytic
poliomyelitis. While strong evidence exists for cell inter-
nal mechanisms codetermining cell type specificity of
poliovirus (Gromeier et al., 1996), the influence of distri-
1
b
t
e
m
s
t
s
2
m
C
t
t
n
p
a
l
c
p
P
p
r
t
o
d
s
i
i
p
t
T
h
c
n
s
t
m
p
i
C
s
C
s
r
t
e
G
1
d
f
(
T
s
m
i
C
t
s
o
s
c
T
t
s
2
t
j
m
s
m
t
a
253DEVELOPMENTAL EXPRESSION OF CD155 IN THE CNSbution of CD155 on the neuropathogenic profile of polio-
virus remained unclear.
CD155 has revealed structural similarities with Ig-like
glycoproteins of insects that are expressed during de-
velopment of the nervous systems (Hellen et al., 1989;
Seeger et al., 1988; Karlstrom et al., 1993; Ramos et al.,
993). Other Ig-like cell-surface glycoproteins have also
een shown to play a crucial role in the development of
he CNS in mammals (see below). Therefore, we consid-
red it possible that CD155 expression may be develop-
entally regulated during embryogenesis of the nervous
ystem.
The strategy to gain insight into the expression pat-
erns and possible function(s) of CD155 was based on
tudies of the CD155 promoter (Solecki et al., 1997, 1999,
000) that have allowed us to generate CD155/LacZ tg
ice. The analyses described here suggest that the
D155 promoter in transgenic animals is selectively ac-
ive in ventral midline structures of the embryonic CNS
hat determine spinal polarity and spinal cord motor
euron induction. CD155 promoter activity became ap-
arent around E10.5 and was observed in the notochord
nd floor plate extending cranially throughout the mye-
encephalon and mesencephalon into the caudal dien-
ephalon, matching the previously drawn borders of floor
late extension (Colamarino and Tessier-Lavigne, 1995;
laczek et al., 1993; Ruiz y Altaba et al., 1993). CD155
romoter activity was also observed coincidental with
etinal ganglion cell axonogenesis and extended along
he path of the optic nerve into the region of the future
ptic chiasm.
The sequence of maturation events leading to the
ifferentiation of motor neurons in the spinal cord (the
ole target of poliovirus in the primate CNS) is schemat-
cally represented in Fig. 7. Short-range and long-range
nductive signals stemming from notochord and floor
late stimulate floor plate and motor neuron differentia-
ion, respectively (reviewed in Tanabe and Jessell, 1996).
hese stimulating signals are transmitted through sonic
edgehog, a factor secreted by notochord and floor plate
ells that has been shown to be essential for motor
euron induction. Strong support for the described as-
ociation of CD155 expression with the developing ven-
ral spinal cord stems from observations of CD155 pro-
oter activation by sonic hedgehog (Solecki et al., un-
ublished results).
The temporospatial pattern of CD155 promoter activity
n CD155/LacZ tg mice was confirmed to correlate to
D155 expression during human development by analy-
es of embryonic tissues of human origin. Expression of
D155 in the human embryonic neuroretina was re-
tricted to the nerve fiber layer around midgestation with
apidly declining levels toward partum.
The expression pattern displayed by CD155 is similar
o known cell adhesion molecules belonging to the IGSF,
.g., Nr-CAM/Bravo (Grumet, 1997), SC1/BEN/DM-RASP (Pollerberg and Mack, 1994), or L1 (Bartsch et al.,
989). A role in the mediation of cell adhesion has been
emonstrated for several members of the CD155-related
amily of genes [e.g., hPRR2 (Lopez et al., 1998), hPRR1
Takahashi et al., 1999), and mPRR2 (Aoki et al., 1997)].
hese findings and the observed developmental expres-
ion pattern of CD155 that matches known adhesion
olecules of the IGSF suggest a physiological function
nvolving the mediation of cell adhesion.
The cell-type- and tissue-specific activity of the 3.0-kb
D155 upstream region in transgenic embryos indicated
hat this genomic fragment harbors cis-acting elements
pecific for directing gene expression to a select subset
f structures within the developing CNS. Genetic analy-
is of the CD155 promoter in tissue culture identified a
ore fragment that possesses four cis-acting elements.
hese motifs together with their corresponding cellular
ranscription factors are likely to contribute to the expres-
ion profile observed in vivo (Solecki et al., 1997, 1999,
000).
We have shown that members of the activator pro-
ein-2 (AP-2) family of transcription factors bind two ad-
acent cis-elements within the CD155 core promoter frag-
ent (Fig. 1; Solecki et al., 1999). Reporter gene expres-
ion driven by the AP-2-responsive CD155 promoter
atches the distribution of AP-2 transcription factors in
he developing neural tube (Mitchell et al., 1991) as well
s the developing retina (Bisgrove et al., 1997). In addi-
tion to AP-2, we have identified nuclear respiratory fac-
tor-1 (NRF-1) to be required for CD155 promoter function
(Fig. 1; Solecki et al., 2000). Like AP-2, NRF-1 belongs to
a family of developmentally regulated transcription fac-
tors (Becker et al., 1998; Virbasius et al., 1993). The nrf
gene, which encodes a protein that shares over 90%
amino acid identity with human NRF-1, is expressed
throughout the developing ocular system and CNS of
zebrafish, paralleling the expression profile of CD155
displayed in CD155/LacZ tg mice (Becker et al., 1998).
The regulation of CD155 promoter activity by transcrip-
tion factors that display their function during embryonic
development of the CNS provides strong corroborating
evidence supporting the in vivo promoter activity we have
observed.
While CD155 can be readily detected immunohisto-
chemically in the human embryonic retina, attempts to
demonstrate CD155 expression in the adult human or
transgenic mouse CNS have failed. In previous studies,
Northern blot analyses revealed significant levels of
CD155-related mRNA in many organs of CD155 trans-
genic mice, including those that do not support poliovi-
rus replication (Ren et al., 1990; Koike et al., 1991). These
experiments should be considered with caution since
they employed crude tissue extracts that contain con-
taminating blood cell populations known to express
CD155 (Freistadt et al., 1993).
Our observations indicate that, similar to its insect
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254 GROMEIER ET AL.FIG. 5. Reporter gene expression within the eye of CD155/LacZ tg mice. (A) The embryonic eye at E12.5 (reproduced with permission from Kaufman).
pe, pigment epithelium; nr, neural retina; od, future optic disk; l, lens; os, optic stalk. (B) The embryonic eye of CD155/LacZ tg mice at E12.5 (180-mm
ryosection). Reporter gene staining product is present within the innermost aspect of the neural retina: retinofugal axons emanating from retinal
anglion cells to form the nerve fiber layer (nfl) extend through the future optic disk into extraocular tissue from the optic stalk. (C) Detail of B; staining
roduct is distributed along the retinofugal axons (arrow) but is absent from retinal ganglion cell somata. Staining of retinofugal fibers extending
hrough the optic disk into the optic stalk indicates reporter gene expression in the developing optic nerve. Scale bars represent 200 mm.
FIG. 6. Immunohistological detection of CD155 in embryonic and adult human retina. Cryosections from fresh frozen embryonic [10 weeksostconception (pc)] (A, B), 16 weeks pc (D, E), and adult (G, H) ocular tissues were subjected to immunohistology as described under Materials and
ethods. For orientation, age-matched cross sections of the developing human retina indicating the anatomical position of the nerve fiber layer and
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255DEVELOPMENTAL EXPRESSION OF CD155 IN THE CNSIGSF relatives, CD155 expression may be developmen-
tally regulated with levels peaking during midgestation.
This would explain the difficulty in detecting CD155
polypeptides in the adult human or CD155 transgenic
mouse CNS. Levels of CD155 expression in the postpar-
tal CNS may simply be too low to be detected immuno-
histochemically. Since susceptibility to poliovirus per-
sists throughout life, we assume that decreasing levels
of CD155 expression in the postpartal spinal cord are
sufficient to mediate infectivity of poliovirus.
We have provided evidence for selective CD155 pro-
moter activity in structures of the evolving CNS giving
rise to spinal cord anterior horn motor neurons. Expres-
sion of CD155 limited to spinal cord anterior horn motor
neurons may be responsible for the exceedingly specific
neuropathogenic profile of poliovirus and the distinctive
clinical manifestations associated with poliovirus neuro-
invasion.
MATERIALS AND METHODS
Cloning of the reporter gene construct
A fragment encompassing 3000 nt of the upstream
region of the CD155 gene (Fig. 1; GenBank Accession
No. X94226) was obtained by PCR from a genomic clone
using primers 59 ccggatccagaagtttgaaaacc and 39 ggct-
gcagccagttgctccgagcagctgg. The putative promoter re-
gion of the CD155 gene was inserted into the PstI site of
vector pSDK.LacZpA128 containing the open reading
frame of b-galactosidase (kindly provided by J. Rossant,
FIG. 7. Schematic diagram of the anatomical relationship of structu
eural plate (A) produces the neural fold (B). Secretion of sonic hedgeho
late (fp) formation in midline neural plate cells. Closure of the neura
ifferentiate within the ventral spinal cord anterior horn (ah; D) in close
o match elements implied in motor neuron differentiation (compare w
the pigment epithelium are shown in C, F, and I. A, D, and G show sec
expected, no staining was observed when ocular sections were incub
monoclonal antibody specifically recognizing CD155 (antibody D171).
embryonic human retina at 10 weeks pc (compare to expression of Lac
CD155 expression was barely detectable in the nerve fiber layer, and the pre
retina (H). The scale bar represents 250 mm.Toronto, Ontario, Canada). The reporter gene construct
was amplified, isolated, and purified by cesium chloride
gradient centrifugation, run twice through a Sephadex
G50 column (Pharmacia), and cut with restriction endo-
nucleases BsaAI and BamHI to remove vectorial se-
quences.
Cell culture, transfection, and reporter gene assays
Ntera-2 (human teratocarcinoma) cells were grown in
Dulbecco’s minimal essential medium and 10% fetal bo-
vine serum (FBS). Raji cells (human Burkitt’s lymphoma)
were grown in RPMI 1640 and 10% FBS. Ntera-2 cells
were transfected with CD155/LacZ cDNA or the promot-
er-less derivative of this vector (SDK.LacZpA128) using
the Lipofectamine Plus Kit (Gibco Life Technologies) fol-
lowing the manufacturer’s instructions. Raji cells were
transfected with these constructs via electroporation at
340 V/1180 mF with a BRL electroporator (electrode gap
.4 cm). Cells were allowed to sit for 10 min at RT and
ere then transferred with fresh medium/serum into cul-
ure flasks. All transfections were standardized by co-
ransfection of pRL-TK (Promega) to monitor transfection
fficiency by measurement of Renilla luciferase. Trans-
ected cells were harvested 18 h posttransfection for the
easurement of b-galactosidase or luciferase activity.
ells were lysed with passive lysis buffer (Promega).
b-Galactosidase activity was assessed photometrically
by using the substrate chlorophenol red-b-D-galactopyr-
anoside. Luciferase enzymatic activity was measured
ucing spinal cord motor neuron differentiation. Midline folding of the
cated by arrows and arrowheads) by notochord (nc) cells induces floor
(C) defines the ventral and dorsal commissures. Motor neurons (mn)
ity to the floor plate. Note the distribution of CD155 promoter activity
4E–4F). Modified from Tanabe and Jessell (1996).
reated with an IgG1 isotype-matched nonspecific control antibody. As
ith the nonspecific control antibody. B, E, and H were treated with a
s strong expression of CD155 in the nerve fiber layer (arrow) of the
nerve fiber layer of CD155/LacZ tg mice; Fig. 5B). At 16 weeks pc (E),res ind
g (indi
l tubetions t
ated w
B show
Z in thesence of CD155 could no longer be demonstrated in the adult human
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256 GROMEIER ET AL.using the Dual Luciferase Assay Kit following the man-
ufacturer’s instructions (Promega).
Generation of transgenic mice
Transgenic mice were generated in an inbred C57/Bl6
background by standard procedures (Hogan et al., 1986).
ransgenic offspring were identified by dot blot hybrid-
zation analysis of genomic DNA using a [a-32P]dCTP-
labeled LacZ DNA probe. Male transgenic mice were
mated with C57/Bl6 females for propagation of individual
founder lines. Females mated with transgenic males
were sacrificed to examine fetuses for LacZ expression
in midgestation.
5-Bromo-4-chloro-3-indolyl-b-D-galactopyranoside
(X-Gal) staining of mouse embryos and tissue
processing
Female C57/Bl6 mice were mated with male trans-
genic founder animals or the male transgenic offspring
of female transgenic founder mice. Timed-pregnant fe-
male mice were sacrificed and perfused with phosphate-
buffered saline (PBS), and their embryos were removed.
Embryos were fixed in 2% neutral buffered paraformal-
dehyde/0.2% glutaraldehyde for 2 h at room temperature.
After being rinsed for 2 h with PBS at 4°C, embryos were
submerged in the staining solution containing 5 mM
K3[Fe(CN)6] and 5 mM K4[Fe(CN)6], 2 mM MgCl, 0.1%
deoxycholate/NP-40, and 1 mg/ml X-Gal (Sigma) in PBS.
Staining was allowed to proceed for 36 h at 36°C, and
embryos were rinsed for 4 h in PBS and postfixed for 30
min in 10% neutral buffered paraformaldehyde at 4°C.
After embryos were rinsed for 2 h in PBS at 4°C they
were submerged in 30% sucrose in PBS overnight,
placed in OCT compound, and gently frozen at 280°C for
20 min for cryostat sectioning. Cryostat sections were
obtained at a thickness of 40 or 180 mm, placed on
silane-treated microscope slides (see below), dried at
room temperature, and counterstained with eosin.
Immunohistochemistry
Cryosections from human tissues were prepared at a
thickness of 4 mm, fixed in cold acetone, and rinsed with
PBS. Sections were blocked with PBS containing 1%
bovine serum albumin and incubated with 5.5 ng/ml
affinity-purified anti-CD155 monoclonal antibody or an
IgG1 isotype-matched control antibody for 1 h at room
temperature. After three washes with PBS, the sections
were incubated with biotinylated anti-mouse polyclonal
antibody (Vector Laboratories, Burlingame, NH) for 1 h at
room temperature and washed with three exchanges of
PBS. Sections were then incubated with a horseradish
peroxidase–streptavidin complex (Vector Laboratories)
for 30 min, rinsed with PBS, and stained with di-amino-
benzidine for 5 min. Sections were counterstained with
hematoxylin, dehydrated, and mounted using standard
Gprocedures. Human tissues were obtained as discarded
material from the Department of Pathology, Duke Univer-
sity Medical Center, using an Institutional Review Board
approved protocol. Gestational age was determined by
dates and measuring the crown–rump length and foot
size.
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